Working… Menu

Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV (TITAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03837756
Recruitment Status : Recruiting
First Posted : February 12, 2019
Last Update Posted : April 19, 2021
Aalborg University Hospital
Odense University Hospital
Rigshospitalet, Denmark
Hvidovre University Hospital
The Peter Doherty Institute for Infection and Immunity
University of Utah
Oslo University Hospital
Information provided by (Responsible Party):
University of Aarhus

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2022
Estimated Study Completion Date : February 28, 2023